These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy]. Xue DB; Ding LJ; Xia AL; Chen D; Xia HP; Teng XD; Xu ST; Zhang SJ; Ren XC Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):671-4. PubMed ID: 21176532 [TBL] [Abstract][Full Text] [Related]
3. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185 [TBL] [Abstract][Full Text] [Related]
5. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235 [TBL] [Abstract][Full Text] [Related]
6. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma. Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914 [TBL] [Abstract][Full Text] [Related]
16. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience. Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897 [TBL] [Abstract][Full Text] [Related]
17. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]
18. Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature. Postovsky S; Beck D; Ben-Izhak O; Arush MW J Pediatr Hematol Oncol; 2001 May; 23(4):257-8. PubMed ID: 11846310 [No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone. Pautier P; Rey A; Haie-Meder C; Kerbrat P; Dutel JL; Gesta P; Bryard F; Morice P; Duvillard P; Lhommé C Int J Gynecol Cancer; 2004; 14(6):1112-7. PubMed ID: 15571617 [TBL] [Abstract][Full Text] [Related]
20. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]